Articles from Cronos Group Inc.

Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million

TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the best-selling cannabis brand in the Canadian market.1 Spinach’s market share outperformance represents Cronos’ relentless commitment to quality, innovation, and bringing differentiated products to the competitive Canadian adult-use market.

TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) is expanding its portfolio for its Lord Jones® brand with new innovations to bolster its lineup of premium cannabis products in the Canadian market. The additions include new cultivars for the Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, which are now available across Canada.

Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 million

TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 second quarter earnings conference call on Thursday, August 8, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration.

TORONTO, July 05, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it will reconvene its 2024 Annual Meeting of Shareholders on Friday, July 19, 2024, at 11:00 a.m. ET.

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) Spinach® brand is expanding its portfolio of award-winning and best-selling cannabis products just in time for the summer months. Summer innovations feature new flavors and formats from Cronos’ SOURZ by Spinach® edibles and a premier milled flower product.

TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the “Meeting”), shareholders holding a total of 274,097,252 common shares of the Company voted in person or by proxy, representing 71.75% of the total number of common shares of the Company outstanding.

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”). GrowCo is a leading cannabis cultivation company that Cronos owns 50% of. The investment will be funded by an additional credit facility provided by Cronos and is intended to assist GrowCo’s expansion of its purpose-built cannabis facility to address the increased global market demand for high-quality cannabis flower.

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET.

TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has terminated its agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). The Buyer did not satisfy or waive its due diligence and financing condition by the May 27, 2024 deadline, as set forth in the Sale Agreement. All amounts paid by the Buyer as part of a security deposit that were previously held in trust have been returned, in accordance with the Sale Agreement. The Company is continuing to evaluate its strategic options for the Peace Naturals Campus, which may include continuing and expanding operations at the facility.

Industry-leading balance sheet with $855 million in cash and cash equivalents

TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW® Pharma, a leading distributor of prescribed medicinal cannabis products in the UK.

TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET.

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced today the launch of Lord Jones® Chocolate Fusions, its exciting first entry into the chocolate edibles category. Cronos’ newest edible innovation was developed and designed by an expert team of culinary chefs, food scientists, and leaders in cannabis product development. The bite-sized Chocolate Fusions™ feature a dynamic, multi-texture experience, combining a soft and chewy center, crunch inclusions, and an outer layer of rich creamy chocolate that delivers a decadent sweet treat for adult cannabis consumers.

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 36th Annual Roth Conference on Monday, March 18, 2024, at 8:30AM PT.

Ended 2023 with approximately $862 million in cash and short-term investments

TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 fourth quarter and full-year earnings conference call on Thursday, February 29, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that its brand, Spinach®, closed 2023 as the number one ranked flower brand in Canada with a 6.9%1 market share in the fourth quarter. Spinach® flower products have resonated strongly with consumers, leading to a significant increase in its ranking from the fourth2 best-selling flower brand in 2022, to become the best-selling flower brand in Canada in 2023.

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution into the Australian market with its first shipment of cannabis flower to Vitura Health Limited (“Vitura”) (ASX: VIT). Cronos owns approximately 10% of the common shares of Vitura, formerly known as Cronos Australia, and will supply cannabis for Vitura.

TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) is proud to announce the launch of its highly anticipated Lord Jones® Live Resin Vapes in two different hardware options. Crafted with the discerning cannabis consumer in mind, these products embody a commitment to excellence, offering an unmatched combination of curated strains, pure live resin, and elegant high-quality hardware.

TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that its wholly owned subsidiary entered into an agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), a vertical farming company, for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the “Peace Naturals Campus”). Pursuant to the terms of the Sale Agreement, the Buyer has agreed to acquire the Peace Naturals Campus for C$23 million cash, subject to the terms and conditions set forth therein. The parties also plan to enter into a lease agreement upon closing for portions of the Peace Naturals Campus, ensuring continued operations.

Industry-leading balance sheet with $840 million in cash and short-term investments

TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has launched its award-winning cannabis brand Lord Jones® in the Canadian adult-use cannabis market. The Lord Jones® brand will build on its legacy of delivering premium quality cannabis products by returning to its roots with bold THC-focused product innovations.

TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced the launch of two new THCV-infused products; Spinach FEELZ™ Full Tilt THCV vape and gummy. Cronos also plans to launch a THCV-infused pre-roll under the Spinach FEELZ™ brand, which will add an additional offering under its robust and growing pre-roll portfolio.

TORONTO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 third quarter earnings conference call on Wednesday, November 8, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its Spinach® brand won “Best Pre-Roll” at the Grow Up Awards this past Sunday for its Spinach® Fully Charged Atomic GMO infused pre-rolls. The annual Grow Up Awards celebrate excellence in the cannabis industry, recognizing outstanding achievements and innovation in a variety of cannabis-related categories.

TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group (“Cansativa”), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

Industry-leading balance sheet with $841 million in cash and short-term investments

TORONTO, July 20, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 second quarter earnings conference call on Tuesday, August 8, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of interest from third parties, each regarding a potential transaction involving Cronos and the third party. Cronos is in the initial stages of reviewing these indications of interest, and there can be no assurance that any agreement or transaction will result therefrom. Cronos does not intend to make any further announcements regarding this matter unless and until required to do so by applicable law.

TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023 (the “Meeting”), shareholders holding a total of 247,410,987 common shares of the Company voted in person or by proxy, representing 64.96% of the total number of common shares of the Company outstanding.

Plans to Exit Existing U.S. hemp-derived CBD Operations

TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, at 1:30PM ET.

TORONTO, May 12, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the Canaccord Genuity 7th Annual Global Cannabis Conference on Thursday, May 18, 2023, at 11:00AM ET.

Industry-leading balance sheet with $836 million in cash and short-term investments

TORONTO, April 28, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 Annual Meeting of Shareholders on Thursday, June 22, 2023, at 11:00 a.m. ET.

TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 first quarter earnings conference call on Tuesday, May 9, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) today, in honor of Earth Day, released a Sustainability Study, which outlines the benefits of using fermentation manufacturing methods for cannabinoid production over the impact of traditional methods of cannabis extraction, which leverage indoor cultivation methods*.

Spinach® rose to 8th place in the pre-roll category, capturing 2.5% market share in Q1 2023, up from 1.4% in Q4 20221

Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021

TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 fourth quarter and full-year earnings conference call on Tuesday, February 28, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

Spinach® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market

TORONTO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that on December 16, 2022, Altria Group, Inc. (“Altria”) notified the Company that its wholly owned subsidiary, Altria Summit LLC, relinquished a warrant to subscribe for and purchase up to 84,243,223 common shares of the Company at a per share exercise price of C$19.00 (the “Warrant”) and all rights that it may have held in the Warrant or any common shares underlying the Warrant for no consideration. The voluntary relinquishment of the Warrant does not affect any rights of Altria under the Investor Rights Agreement between the Company and Altria, dated March 8, 2019. Altria continues to beneficially own 156,573,537 common shares of the Company and has four designees on the board of the Company, one of whom is independent.

TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced the launch of a CBC-focused product, the Spinach FEELZ™ THC+CBC Day Trip Mango Lime gummies, utilizing Ginkgo Bioworks’ platform for organism design and development.

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada’s 3rd Annual Future of Healthcare Conference on Wednesday, December 7, 2022 at 1:00 p.m. ET.

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of James Holm as Chief Financial Officer, effective immediately. Mr. Holm succeeds Bob Madore, who is leaving the Company.

Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million

TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that it has reached final settlement agreements with each of the U.S. Securities and Exchange Commission (the “SEC”) and the Staff of the Ontario Securities Commission (the “OSC”) that resolve those regulators’ investigations regarding the previously disclosed restatements by the Company of its financial statements for the first three quarters of 2019 and the second quarter of 2021.

TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQCRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 third quarter earnings conference call on Monday, November 7, 2022 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.